CHIEF SCIENTIFIC OFFICER · Structure Therapeutics Inc. · Structure Therapeutics Inc. — American Depositary Shares
Side
SELL
Value
$160K
Shares
3,020
Price
$53.13
Executed
Aug 18, 2026
Disclosed
Aug 19, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 18 executedAug 19, 2026 disclosed
GPCR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Structure Therapeutics Inc. — American Depositary Shares
Ticker
GPCR
Shares
3,020
Price per share
$53.13
Value
$160,462
Execution date (reported)
Aug 18, 2026
Owned after transaction
919 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
1
Calculation
Value = shares × reported price per share
Shares: 3,020
Price: $53.133
= $160,462
What this establishes
Lin Xichen filed this Form 4 reporting a open-market sale of GPCR on Aug 18, 2026. It became public on Aug 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF SCIENTIFIC OFFICER
Lin Xichencik:0001962926
Issuer
Structure Therapeutics Inc.cik:0001888886
Revision history · 0
No field has changed since this record was first ingested.
